Enovis Corp
General ticker "ENOV" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.6B
Enovis Corp does not follow the US Stock Market performance with the rate: -13.9%.
Estimated limits based on current volatility of 2.2%: low 42.40$, high 44.33$
Factors to consider:
- US accounted for 67.5% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [45.21$, 74.80$]
- 2024-12-30 to 2025-12-30 estimated range: [54.73$, 86.35$]
Financial Metrics affecting the ENOV estimates:
- Positive: Non-GAAP EPS, $ of 2.40 > 2.29
- Negative: Operating profit margin, % of -3.71 <= 1.03
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of 4.76 <= 7.18
Short-term ENOV quotes
Long-term ENOV plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,426.19MM | $1,599.81MM | $1,707.20MM |
| Operating Expenses | $1,488.99MM | $1,670.98MM | $1,772.91MM |
| Operating Income | $-62.80MM | $-71.18MM | $-65.71MM |
| Non-Operating Income | $-58.98MM | $69.11MM | $-1.42MM |
| Interest Expense | $72.59MM | $24.05MM | $19.75MM |
| R&D Expense | $49.09MM | $60.83MM | $75.33MM |
| Income(Loss) | $-121.78MM | $-2.07MM | $-67.13MM |
| Taxes | $-19.53MM | $36.12MM | $-13.29MM |
| Other Income(Loss) | $178.53MM | $26.43MM | $21.11MM |
| Profit(Loss) | $76.28MM | $-11.76MM | $-32.73MM |
| Stockholders Equity | $4,617.38MM | $3,448.09MM | $3,418.39MM |
| Inventory | $776.29MM | $426.64MM | $468.83MM |
| Assets | $8,515.91MM | $4,273.25MM | $4,509.33MM |
| Operating Cash Flow | $356.10MM | $-55.86MM | $134.99MM |
| Capital expenditure | $104.24MM | $105.45MM | $122.22MM |
| Investing Cash Flow | $-320.48MM | $-176.39MM | $-242.47MM |
| Financing Cash Flow | $584.91MM | $-465.13MM | $127.80MM |
| Earnings Per Share* | $1.93 | $-0.71 | $-1.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.